Expression of ARF4 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

ARF4 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 178.85

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

197.6

Number of samples

141

Samples

Sample	Description	TPM
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	594.0
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	445.7
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	420.4
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	417.0
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	381.7
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	354.0
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	343.7
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	338.9
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	316.7
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	292.1
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	284.8
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	276.4
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	274.5
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	271.8
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	270.9
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	260.2
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	255.5
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	255.2
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	252.2
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	248.9
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	247.5
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	246.6
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	241.2
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	240.6
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	240.1
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	238.6
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	233.2
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	232.9
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	232.5
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	231.2
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	228.8
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	227.2
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	220.3
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	217.0
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	216.9
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	216.2
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	215.1
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	215.0
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	213.2
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	212.4
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	211.8
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	210.4
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	209.8
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	209.4
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	208.9
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	207.7
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	207.4
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	207.3
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	207.2
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	206.3
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	205.7
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	202.3
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	200.8
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	200.5
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	197.0
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	195.9
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	194.3
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	193.5
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	193.2
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	189.7
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	188.8
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	188.1
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	187.2
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	186.7
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	186.3
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	185.5
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	184.0
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	183.7
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	182.3
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	182.1
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	181.1
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	180.5
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	180.0
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	180.0
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	179.1
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	179.0
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	178.7
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	178.5
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	178.3
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	177.2
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	176.9
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	176.8
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	176.7
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	175.1
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	174.8
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	174.5
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	173.6
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	173.5
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	173.3
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	172.7
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	171.8
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	170.3
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	169.0
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	167.2
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	166.4
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	166.4
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	166.3
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	165.7
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	165.3
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	165.3
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	165.0
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	163.4
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	163.3
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	162.9
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	162.6
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	162.2
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	160.4
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	160.2
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	159.8
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	158.4
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	156.0
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	155.5
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	153.0
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	151.6
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	150.0
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	147.0
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	146.0
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	144.4
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	141.6
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	140.4
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	140.0
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	137.9
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	137.5
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	135.2
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	135.0
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	132.5
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	131.9
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	128.6
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	125.7
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	125.1
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	124.8
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	120.6
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	120.5
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	114.1
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	110.1
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	109.5
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	104.5
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	102.2
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	99.8
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	97.5
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	77.6
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

ARF4 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 47.52

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

58.1

Number of samples

Samples

Sample	Description	TPM
AK153	N, NA, stage:NA, dead, 240 days	180.4
AK051	N, NA, stage:NA, dead, 360 days	133.6
AK218	N, NA, stage:NA, dead, 180 days	114.2
AK003	N, NA, stage:NA, dead, 600 days	112.7
AK236	N, NA, stage:NA, dead, 360 days	98.7
AK149	N, NA, stage:NA, dead, 420 days	90.3
AK002	N, NA, stage:NA, dead, 570 days	84.2
AK117	N, NA, stage:NA, dead, 210 days	83.8
AK133	N, NA, stage:NA, dead, 360 days	83.3
AK156	N, NA, stage:NA, dead, 330 days	83.0
AK183	N, NA, stage:NA, alive, 360 days	82.8
AK043	N, NA, stage:NA, alive, 660 days	74.2
AK123	N, NA, stage:NA, dead, 180 days	68.0
AK005	N, NA, stage:NA, dead, 240 days	62.3
AK030	N, NA, stage:NA, dead, 120 days	60.7
AK188	N, NA, stage:NA, alive, 420 days	60.3
AK173	N, NA, stage:NA, dead, 180 days	59.0
AK142	N, NA, stage:NA, alive, 90 days	57.7
AK081	N, NA, stage:NA, dead, 180 days	57.3
AK199	N, NA, stage:NA, alive, 1860 days	56.1
AK195	N, NA, stage:NA, dead, 390 days	55.6
AK068	N, NA, stage:NA, alive, 360 days	55.1
AK099	N, NA, stage:NA, dead, 420 days	55.0
AK227	N, NA, stage:NA, alive, 300 days	54.2
AK049	N, NA, stage:NA, dead, 180 days	54.0
AK139	N, NA, stage:NA, dead, 270 days	53.8
AK074	N, NA, stage:NA, alive, 300 days	53.5
AK076	N, NA, stage:NA, alive, 660 days	51.8
AK071	N, NA, stage:NA, dead, 540 days	51.6
AK079	N, NA, stage:NA, dead, 210 days	51.4
AK226	N, NA, stage:NA, dead, 360 days	50.8
AK055	N, NA, stage:NA, dead, 240 days	50.8
AK072	N, NA, stage:NA, dead, 150 days	48.6
AK185	N, NA, stage:NA, alive, 330 days	48.5
AK098	N, NA, stage:NA, dead, 660 days	48.3
AK091	N, NA, stage:NA, dead, 210 days	48.0
AK216	N, NA, stage:NA, dead, 360 days	47.8
AK178	N, NA, stage:NA, dead, 240 days	47.5
AK165	N, NA, stage:NA, alive, 360 days	47.5
AK089	N, NA, stage:NA, dead, 330 days	47.2
AK041	N, NA, stage:NA, alive, 810 days	45.3
AK103	N, NA, stage:NA, alive, 1320 days	44.7
AK158	N, NA, stage:NA, dead, 360 days	44.3
AK035	N, NA, stage:NA, dead, 210 days	44.1
AK100	N, NA, stage:NA, alive, 960 days	43.8
AK053	N, NA, stage:NA, dead, 300 days	41.5
AK134	N, NA, stage:NA, dead, 360 days	39.6
AK205	N, NA, stage:NA, dead, 120 days	39.3
AK006	N, NA, stage:NA, dead, 360 days	36.4
AK088	N, NA, stage:NA, dead, 360 days	36.2
AK085	N, NA, stage:NA, alive, 660 days	36.0
AK167	N, NA, stage:NA, dead, 180 days	35.7
AK066	N, NA, stage:NA, alive, 960 days	35.2
AK231	N, NA, stage:NA, dead, 240 days	28.7
AK124	N, NA, stage:NA, alive, 1920 days	25.6
AK015	N, NA, stage:NA, alive, 720 days	24.3
AK102	N, NA, stage:NA, alive, 1740 days	23.9
AK213	N, NA, stage:NA, alive, 2010 days	22.6
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0206110003	Tumor	0.6
CPT0221180003	Tumor	0.5
CPT0204350003	Normal	0.5
CPT0206450003	Tumor	0.4
CPT0087730003	Tumor	0.4
CPT0217880003	Tumor	0.4
CPT0204330003	Normal	0.4
CPT0204390003	Normal	0.4
CPT0189650004	Tumor	0.4
CPT0205570003	Tumor	0.4
CPT0204410003	Normal	0.4
CPT0217000004	Tumor	0.3
CPT0205450004	Tumor	0.3
CPT0204420003	Normal	0.3
CPT0206560003	Tumor	0.3
CPT0125570003	Tumor	0.3
CPT0087570003	Tumor	0.3
CPT0206230003	Tumor	0.3
CPT0206880003	Tumor	0.3
CPT0219080004	Tumor	0.3
CPT0204400003	Normal	0.3
CPT0162100003	Tumor	0.3
CPT0087950003	Tumor	0.2
CPT0204360003	Normal	0.2
CPT0162020003	Tumor	0.2
CPT0189460003	Tumor	0.2
CPT0104220003	Tumor	0.2
CPT0093550003	Tumor	0.2
CPT0217060003	Tumor	0.2
CPT0217430008	Tumor	0.2
CPT0196850003	Tumor	0.2
CPT0218770003	Tumor	0.1
CPT0204340003	Normal	0.1
CPT0168380003	Tumor	0.1
CPT0089150003	Tumor	0.1
CPT0204380003	Normal	0.1
CPT0190360004	Tumor	0.1
CPT0175060003	Tumor	0.1
CPT0186100003	Tumor	0.1
CPT0209440003	Tumor	0.1
CPT0093360003	Tumor	0.1
CPT0218330004	Tumor	0.1
CPT0206000004	Tumor	0.1
CPT0002410011	Tumor	0.1
CPT0189850004	Tumor	0.1
CPT0205780003	Tumor	0.1
CPT0168830003	Tumor	0.1
CPT0125220003	Tumor	0.1
CPT0093590003	Tumor	0.1
CPT0182500003	Tumor	0.0
CPT0216920008	Tumor	0.0
CPT0127480003	Tumor	0.0
CPT0064890003	Tumor	0.0
CPT0168590003	Tumor	0.0
CPT0167640003	Tumor	0.0
CPT0205890003	Tumor	0.0
CPT0167750004	Tumor	0.0
CPT0168720003	Tumor	0.0
CPT0205670004	Tumor	0.0
CPT0199770003	Tumor	0.0
CPT0207090003	Tumor	0.0
CPT0071100003	Tumor	0.0
CPT0182580003	Tumor	0.0
CPT0218690004	Tumor	0.0
CPT0168270003	Tumor	0.0
CPT0182550003	Tumor	0.0
CPT0167860004	Tumor	0.0
CPT0189250003	Tumor	0.0
CPT0224330003	Tumor	-0.1
CPT0168080003	Tumor	-0.1
CPT0167530003	Tumor	-0.1
CPT0079790003	Tumor	-0.1
CPT0078580003	Tumor	-0.1
CPT0201710003	Tumor	-0.1
CPT0206330003	Tumor	-0.1
CPT0093450003	Tumor	-0.1
CPT0127420003	Tumor	-0.1
CPT0168480003	Tumor	-0.1
CPT0228220003	Tumor	-0.1
CPT0125510003	Tumor	-0.1
CPT0217190003	Tumor	-0.1
CPT0206780003	Tumor	-0.1
CPT0217710008	Tumor	-0.1
CPT0093510003	Tumor	-0.1
CPT0208980003	Tumor	-0.1
CPT0217100003	Tumor	-0.1
CPT0161730003	Tumor	-0.1
CPT0064650003	Tumor	-0.1
CPT0167970003	Tumor	-0.1
CPT0204370003	Normal	-0.1
CPT0206670004	Tumor	-0.1
CPT0225730003	Tumor	-0.2
CPT0189750004	Tumor	-0.2
CPT0104330003	Tumor	-0.2
CPT0190240004	Tumor	-0.2
CPT0224600003	Tumor	-0.2
CPT0207030003	Tumor	-0.2
CPT0189570004	Tumor	-0.2
CPT0162140003	Tumor	-0.2
CPT0087680003	Tumor	-0.2
CPT0092440003	Tumor	-0.2
CPT0224390004	Tumor	-0.2
CPT0218890004	Tumor	-0.2
CPT0123530003	Tumor	-0.2
CPT0218670003	Tumor	-0.3
CPT0225760003	Tumor	-0.3
CPT0224540004	Tumor	-0.3
CPT0218830004	Tumor	-0.4
CPT0171580008	Tumor	-0.5
CPT0218960004	Tumor	-0.6
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis